By contrast, pancreatic cell lines resistant to gemcitabine showed hyper-activated PI3K/AKT signaling, but not increased apoptosis suggesting that the mechanisms inducing chemotherapy resistance is different depending on the type of cancer and drug [29]. The gene discussed is AKT1; the disease is cancer.